Want to see IN:BHARATRAS full AI Analyst Report?
Top Page
Bharat Rasayan Limited
(BHARATRAS)
Select Model
Select Model
Rating:67Neutral
Price Target:
₹1,011.00
▼(-20.38% Downside)
Action:Downgraded
Date:08/28/26
The overall score is supported by strong underlying financial quality (especially the very low-debt balance sheet) and attractive valuation (low P/E with a ~3% yield). However, weak technical momentum and the business’s cash-flow/revenue volatility materially reduce the score.
Positive Factors
Very low leverage
The near-zero debt-to-equity position gives Bharat Rasayan substantial financial flexibility and low solvency risk. A lightly leveraged balance sheet can support investment in capacity or products while reducing the pressure that interest obligations would create during weaker agrochemical cycles.
Negative Factors
Revenue cyclicality
The pattern of declines followed by a sharp rebound shows that Bharat Rasayan’s revenue base is cyclical rather than consistently expanding. Such variability can make capacity planning, customer demand forecasting, and earnings visibility more difficult over the next several quarters, even when annual growth recovers.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage
The near-zero debt-to-equity position gives Bharat Rasayan substantial financial flexibility and low solvency risk. A lightly leveraged balance sheet can support investment in capacity or products while reducing the pressure that interest obligations would create during weaker agrochemical cycles.
Read all positive factors
Bharat Rasayan Limited (BHARATRAS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹15.49B
Dividend Yield0.05%
Average Volume (3M)1.57K
Price to Earnings (P/E)6.9
Beta (1Y)1.52
Revenue Growth-5.17%
EPS Growth4.24%
CountryIN
Employees903
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)136.53
Shares Outstanding16,621,073
10 Day Avg. Volume1,302
30 Day Avg. Volume1,573
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)1.58
Price to Sales (P/S)1.62
P/FCF Ratio36.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bharat Rasayan Limited Business Overview & Revenue Model
Company Description
Established in 1989 and headquartered in New Delhi, India, Bharat Rasayan Limited is a key producer and distributor of agrochemical products. The company specializes in technical grade pesticides, encompassing insecticides, herbicides, and fungici...
How the Company Makes Money
Bharat Rasayan Limited primarily makes money by manufacturing and selling agrochemical products across the crop protection value chain. Its core revenue stream is the sale of technical-grade active ingredients (i.e., concentrated, technical materi...
Bharat Rasayan Limited Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
92
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.03B | 12.42B | 11.73B | 10.45B | 12.34B | 12.95B |
| Gross Profit | 3.01B | 3.19B | 3.96B | 3.24B | 3.95B | 3.69B |
| EBITDA | 1.95B | 2.24B | 2.01B | 1.38B | 2.06B | 2.66B |
| Net Income | 1.43B | 1.46B | 1.41B | 955.10M | 1.25B | 1.76B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 14.33B | 14.08B | 11.97B | 10.74B | 10.86B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.73B | 2.86B | 1.41B | 485.96M | 66.88M |
| Total Debt | 0.00 | 12.26M | 852.19M | 804.74M | 279.37M | 1.74B |
| Total Liabilities | -12.75B | 1.58B | 2.78B | 2.10B | 1.80B | 3.16B |
| Stockholders Equity | 12.75B | 12.75B | 11.30B | 9.88B | 8.93B | 7.70B |
Cash Flow | ||||||
| Free Cash Flow | -161.72M | 545.22M | 1.32B | 140.26M | 1.90B | -1.21B |
| Operating Cash Flow | 249.00K | 1.28B | 1.68B | 410.76M | 2.13B | -654.55M |
| Investing Cash Flow | -173.93M | -963.94M | -1.57B | -897.00M | -605.49M | 511.36M |
| Financing Cash Flow | 23.25M | -846.16M | 41.22M | 489.57M | -1.52B | -247.85M |
Bharat Rasayan Limited Technical Analysis
Negative
1269.75
Price Trends
1095.26
Negative
1222.03
Negative
1384.12
Negative
Market Momentum
-43.58
Negative
27.78
Positive
12.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BHARATRAS, the sentiment is Negative. The current price of 1269.75 is above the 20-day moving average (MA) of 971.36, above the 50-day MA of 1095.26, and below the 200-day MA of 1384.12, indicating a bearish trend. The MACD of -43.58 indicates Negative momentum. The RSI at 27.78 is Positive, neither overbought nor oversold. The STOCH value of 12.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BHARATRAS.
Bharat Rasayan Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹43.75B | 16.48 | ― | 0.20% | -5.63% | -11.38% | |
67 Neutral | ₹15.49B | 6.86 | ― | 0.05% | -5.17% | 4.24% | |
63 Neutral | ₹35.75B | 18.14 | ― | 1.63% | 6.82% | 11.93% | |
56 Neutral | ₹316.94B | 27.34 | ― | 0.71% | -16.57% | -27.71% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ₹15.10B | 11.82 | ― | 0.39% | 1.26% | -16.43% | |
55 Neutral | ₹12.97B | 12.05 | ― | 0.67% | 17.05% | 9.10% |
* General Sector Average
IN:BHARATRAS
Bharat Rasayan Limited
931.80
-1,781.65
-65.66%
IN:DHANUKA
Dhanuka Agritech Limited
981.50
-390.11
-28.44%
IN:INSECTICID
Insecticides (India) Limited
519.10
-195.47
-27.36%
IN:IPL
India Pesticides Ltd.
112.60
-76.28
-40.39%
IN:PIIND
PI Industries Limited
2,089.00
-1,466.32
-41.24%
IN:RALLIS
Rallis India Limited
183.85
-71.43
-27.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.